What is FreeThink Technologies?
FreeThink Technologies is a prominent provider of pharmaceutical stability and formulation solutions. The company offers a comprehensive suite of services, including advanced stability software, analytical laboratory testing, formulation development, and packaging expertise. Their core mission is to expedite the product development lifecycle for clients by tackling complex challenges related to product shelf life, solubility enhancement, and controlled drug delivery through sophisticated scientific methodologies. Notably, FreeThink's ASAPprime software is designed to accurately determine product shelf life under highly accelerated conditions, ensuring efficient project management and timely delivery of quality results worldwide.
How much funding has FreeThink Technologies raised?
FreeThink Technologies has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for FreeThink Technologies?
With the recent injection of capital, FreeThink Technologies is poised for accelerated expansion and further innovation in pharmaceutical R&D. The 'large-scale late-stage funding' context suggests a strategic focus on scaling operations, enhancing its technological infrastructure, and potentially broadening its market reach. This investment will likely fuel advancements in its stability software and analytical services, enabling the company to address an increasing demand for efficient and reliable product development solutions in the competitive pharmaceutical industry. The company's commitment to cutting-edge science and efficient project coordination positions it for continued leadership in formulation and stability.
See full FreeThink Technologies company page
